Biomarker evaluation as a potential cause of gender differences in obesity paradox among patients with STEMI




Abstract


Background


Obesity with its worldwide growing prevalence is an established cardiovascular risk factor with increased morbidity and mortality. However, the phenomenon, that mild to moderate obesity seems to represent a protective effect on diseases has been termed the “obesity paradox”.


Methods


We retrospectively assessed 529 patients (72.6% male, mean age 59.7 ± 12.7 years) admitted with ST-elevation myocardial infarction (STEMI). The female and male study populations were separated into four body mass index (BMI) groups: ≤ 24.9 kg/m 2 , 25.0–29.9 kg/m 2 , 30.0–34.9 kg/m 2 and ≥ 35.0 kg/m 2 . Blood samples of high-density lipoprotein cholesterol (HDL-c) and low-density lipoprotein cholesterol (LDL-c) were analyzed.


Results


With increasing BMI group the rate of major adverse cardiac events (MACE) decreased in all patients (test for trend p = 0.041). No gender difference between MACE and BMI could be noticed ( p = 0.16). A higher risk for MACE was indicated in group BMI ≤ 18.5 kg/m 2 in comparison to group BMI 25.0–29.9 kg/m 2 (OR: 7.93; 95% CI: 1.75–35.89; p = 0.0091), whereas group BMI 30.0–34.9 kg/m 2 was significant associated with a lower risk in comparison to group BMI 25.0–29.9 kg/m 2 (OR: 0.65; 95% CI: 0.21–1.96; p = 0.044). An association between HDL-c ( p = 0.55) or LDL-c ( p = 0.10) and MACE could not be detected.


Conclusion


The study demonstrates that patients with STEMI and a BMI of 30.0–34.9 kg/m 2 have a decreased risk for MACE compared to patients with normal BMI. No gender related differences were indicated. An association between MACE and lipoproteins could not be detected.


Highlights





  • Higher risk for MACE was shown in group BMI ≤ 24.9 kg/m 2 compared to BMI 25.0–29.9 kg/m 2 .



  • The study showed no association between HDL-c ( p = 0.55) or LDL-c ( p = 0.10) and MACE.



  • No gender difference between MACE and BMI could be detected ( p = 0.16).




Introduction


Obesity is a serious public health care problem in industrialized nations with growing prevalence . In overweight patients the risk of all-cause mortality is markedly increased over all age groups in men and women . As a well-established risk factor for developing diabetes and hypertension, obesity has a substantial impact on cardiovascular diseases and mortality . Dyslipidemia is caused by obesity and especially the combination of low high-density lipoprotein cholesterol (HDL-c) and high low-density lipoprotein cholesterol (LDL-c) levels as well as elevated triglyceride levels are a predictor for cardiovascular events .


Surprisingly several previously published studies indicated, that mild obesity has a protective role in patients with obstructive lung disease, end-stage renal disease, advanced cancer as well as in several cardiovascular disorders . Thus it is discussed that even patients with acute myocardial infarction might benefit from mild obesity . In the literature there are only a few studies focusing on gender differences in the “obesity paradox” achieving inconsistent results . There are indications that overweight women may have a decreased risk for acute myocardial infarction, whereas their male counterparts have an increased risk .


The purpose of the present study was to investigate gender related differences and the influence of different biomarkers reflecting the nutritional status and body mass index (BMI) on in-hospital major adverse cardiac events (MACE) in patients with ST-elevation myocardial infarction (STEMI).

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Nov 13, 2017 | Posted by in CARDIOLOGY | Comments Off on Biomarker evaluation as a potential cause of gender differences in obesity paradox among patients with STEMI

Full access? Get Clinical Tree

Get Clinical Tree app for offline access